Bio-Rad Laboratories, Inc. Class A Common Stock (BIO)

Accounts Payable

$143.50M

Quarterly · Period ending: Jun 30, 2026 · USD

BIO Accounts Payable

Latest reported$143.50Mperiod endingJun 30, 2026

BIO Quarterly Accounts Payable ($0.00 → $143.50M)

Quarterly accounts payable

High-resolution chart · PNG

BIO accounts payable history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Bio-Rad Laboratories, Inc. Class A Common Stock Accounts Payable — Quarterly (USD)
Period ending	Accounts Payable (USD)
Jun 30, 2026	143,500,000
Mar 31, 2026	133,100,000
Dec 31, 2025	129,000,000
Sep 30, 2025	128,800,000
Jun 30, 2025	139,300,000
Mar 31, 2025	137,900,000
Dec 31, 2024	122,300,000
Sep 30, 2024	122,185,000
Jun 30, 2024	126,693,000
Mar 31, 2024	102,750,000
Dec 31, 2023	144,625,000
Sep 30, 2023	111,859,000
Jun 30, 2023	149,535,000
Mar 31, 2023	160,979,000
Dec 31, 2022	135,041,000
Sep 30, 2022	142,746,000
Jun 30, 2022	158,259,000
Mar 31, 2022	160,651,000
Dec 31, 2021	141,941,000
Sep 30, 2021	136,398,000
Jun 30, 2021	133,457,000
Mar 31, 2021	138,494,000
Dec 31, 2020	139,451,000
Sep 30, 2020	132,994,000
Jun 30, 2020	130,905,000
Mar 31, 2020	118,221,000
Dec 31, 2019	107,014,000
Sep 30, 2019	249,835,000
Jun 30, 2019	246,809,000
Mar 31, 2019	239,018,000
Dec 31, 2018	122,450,000
Sep 30, 2018	257,028,000
Jun 30, 2018	261,721,000
Mar 31, 2018	259,365,000
Dec 31, 2017	135,182,000
Sep 30, 2017	273,958,000
Jun 30, 2017	277,566,000
Mar 31, 2017	231,485,000
Dec 31, 2016	133,109,000
Sep 30, 2016	280,453,000
Jun 30, 2016	256,112,000
Mar 31, 2016	241,249,000
Dec 31, 2015	122,391,000
Sep 30, 2015	268,228,000
Jun 30, 2015	239,847,000
Mar 31, 2015	250,813,000
Dec 31, 2014	128,608,000
Sep 30, 2014	126,640,000
Jun 30, 2014	125,461,000
Mar 31, 2014	130,864,000
Dec 31, 2013	148,510,000
Sep 30, 2013	131,899,000
Jun 30, 2013	129,119,000
Mar 31, 2013	119,340,000
Dec 31, 2012	130,867,000
Sep 30, 2012	113,282,000
Jun 30, 2012	119,448,000
Mar 31, 2012	109,571,000
Dec 31, 2011	129,124,000
Sep 30, 2011	113,476,000
Jun 30, 2011	120,514,000
Mar 31, 2011	111,373,000
Dec 31, 2010	113,440,000
Sep 30, 2010	99,120,000
Jun 30, 2010	95,161,000
Mar 31, 2010	99,160,000
Dec 31, 2009	92,988,000
Sep 30, 2009	92,381,000
Jun 30, 2009	90,850,000
Mar 31, 2009	95,952,000
Dec 31, 2008	117,982,000
Sep 30, 2008	100,626,000
Jun 30, 2008	102,320,000
Mar 31, 2008	98,929,000
Dec 31, 2007	96,470,000
Sep 30, 2007	68,102,000
Jun 30, 2007	67,229,000
Mar 31, 2007	61,946,000
Dec 31, 2006	83,411,000
Sep 30, 2006	64,513,000
Jun 30, 2006	69,302,000
Mar 31, 2006	66,643,000
Dec 31, 2005	72,950,000
Sep 30, 2005	68,076,000
Jun 30, 2005	69,254,000
Mar 31, 2005	67,145,000
Dec 31, 2004	71,194,000
Sep 30, 2004	55,524,000
Jun 30, 2004	67,340,000
Mar 31, 2004	57,033,000
Dec 31, 2003	53,995,000
Sep 30, 2003	60,516,000
Jun 30, 2003	52,891,000
Mar 31, 2003	79,001,000
Dec 31, 2002	75,233,000
Sep 30, 2002	68,496,000
Jun 30, 2002	69,414,000
Mar 31, 2002	67,848,000
Dec 31, 2001	64,903,000
Sep 30, 2001	67,835,000